Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Contentious screening decisions: does the choice matter?

Pauker SG, Kassirer JP.

N Engl J Med. 1997 Apr 24;336(17):1243-4. No abstract available.

PMID:
9110913
2.

Liability for failure to order screening examinations.

Berlin L.

AJR Am J Roentgenol. 2002 Dec;179(6):1401-5. No abstract available.

PMID:
12438024
3.

How did the PSA system arise?

Justman S.

J R Soc Med. 2010 Aug 1;103(8):309-12. doi: 10.1258/jrsm.2010.100130. Epub 2010 Jul 7. No abstract available.

4.

Re: Public knowledge of benefits of breast and prostate cancer screening in Europe.

Brenner H, Heywang-Köbrunner S, Becker N.

J Natl Cancer Inst. 2010 Mar 3;102(5):356; author reply 356-7. doi: 10.1093/jnci/djp516. Epub 2010 Jan 14. No abstract available.

PMID:
20075365
5.

Re: Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005.

Belpomme D, Irigaray P.

J Natl Cancer Inst. 2010 Apr 7;102(7):506-7. doi: 10.1093/jnci/djq045. Epub 2010 Feb 26. No abstract available.

PMID:
20190186
6.

[Screening for cancer].

Caicoya Gómez-Morán M.

Aten Primaria. 1995 Oct 31;16(7):441-4, 446-52. Review. Spanish. No abstract available.

PMID:
7495955
7.

The mammography and prostate-specific antigen controversies: implications for patient-physician encounters and public policy.

Brett AS.

J Gen Intern Med. 1995 May;10(5):266-70. Review. No abstract available.

PMID:
7542328
8.

Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.

Carrasco-Garrido P, Hernandez-Barrera V, Lopez de Andres A, Jimenez-Trujillo I, Gallardo Pino C, Jimenez-Garcıa R.

Eur J Public Health. 2014 Apr;24(2):264-70. doi: 10.1093/eurpub/ckt089. Epub 2013 Jun 27.

PMID:
23813710
9.

Prostate-specific antigen screening in prostate cancer: perspectives on the evidence.

Wilt TJ, Scardino PT, Carlsson SV, Basch E.

J Natl Cancer Inst. 2014 Mar;106(3):dju010. doi: 10.1093/jnci/dju010. Epub 2014 Mar 4. No abstract available.

12.

Prostate cancer: 4. Screening.

Meyer F, Fradet Y.

CMAJ. 1998 Oct 20;159(8):968-72. Review. No abstract available.

13.

Mammography, routine ultrasonography in pregnancy, and PSA screenings in Italy.

Favaretti C, De Pieri P.

Int J Technol Assess Health Care. 2001 Summer;17(3):358-68.

PMID:
11495379
14.

[Counseling for cancer screening. Offer the facts instead of false promises].

Klein F.

MMW Fortschr Med. 2010 Nov 25;152(47):14-7. German. No abstract available.

PMID:
21226371
16.

Evaluation of preventive technologies in Germany: case studies of mammography, prostate cancer screening, and fetal ultrasound.

Perleth M, Busse R, Gibis B, Brand A.

Int J Technol Assess Health Care. 2001 Summer;17(3):329-37.

PMID:
11495377
17.

Rethinking screening for breast cancer and prostate cancer.

Esserman L, Shieh Y, Thompson I.

JAMA. 2009 Oct 21;302(15):1685-92. doi: 10.1001/jama.2009.1498.

PMID:
19843904
18.

Lung cancer screening gets risk-specific.

Peres J.

J Natl Cancer Inst. 2013 Jan 2;105(1):1-2. doi: 10.1093/jnci/djs631. Epub 2012 Dec 20. No abstract available.

PMID:
23257155
19.

What is the difference between screening and diagnostic tests?

[No authors listed]

Johns Hopkins Med Lett Health After 50. 2002 Jul;14(5):8. No abstract available.

PMID:
12154802
20.

Chances and risks in medical risk communication.

Hoffrage U, Koller M.

Ger Med Sci. 2015 Jul 9;13:Doc07. doi: 10.3205/000211. eCollection 2015.

Supplemental Content

Support Center